Clinical trial
Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated…
NCT00379262 · Hong Kong Nasopharyngeal Cancer Study Group Limited, Other · Completed
Key facts
| NCT number | NCT00379262 |
|---|---|
| Title | Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma |
| Official title | Randomized Trial to Evaluate Therapeutic Gain by Changing Chemoradiotherapy From Concurrent-adjuvant to Induction-concurrent Sequence, and Radiotherapy From Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma |
| Lead sponsor | Hong Kong Nasopharyngeal Cancer Study Group Limited, Other |
| Collaborators | The Hong Kong Anti-Cancer Society hong Kong Cancer Fund |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nasopharyngeal Carcinoma |
| Intervention type | Drug |
| Interventions | Capecitabine, Adjuvant chemotherapy using PF (5-Fluorouracil ), Induction chemotherapy using PF (5-Fluorouracil) |
| Enrollment | 803 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2017 |
| Completion | Dec 1, 2018 |
| First posted | Sep 21, 2006 |
| Last update posted | Aug 7, 2019 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: